Lauren Merendino

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lauren Merendino:

Company Role Class Num Shares Value Price $ Report Date Ownership
Day One Biopharmaceuticals, Inc. Chief Commercial Officer Common Stock 50,809 $452,946 $8.91 17 Nov 2025 Direct
Day One Biopharmaceuticals, Inc. Chief Commercial Officer Stock Option (right to buy Common Stock) 110,000 30 Jan 2026 Direct
Day One Biopharmaceuticals, Inc. Chief Commercial Officer Restricted Stock Units 74,000 30 Jan 2026 Direct
Day One Biopharmaceuticals, Inc. Chief Commercial Officer Restricted Stock Unit (RSU) 44,252 15 Nov 2025 Direct
ESSA Pharma Inc. Director Options 25,000 25 Mar 2024 Direct
Myovant Sciences Ltd. Chief Commercial Officer Common Shares 0 $27.00 10 Mar 2023 Direct
Myovant Sciences Ltd. Chief Commercial Officer Performance Stock Unit 0 10 Mar 2023 Direct
Myovant Sciences Ltd. Chief Commercial Officer Stock Options (Right to Buy) 0 10 Mar 2023 Direct

Insider Reports Filed by Lauren Merendino

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DAWN Day One Biopharmaceuticals, Inc. 30 Jan 2026 2 $0 4 Chief Commercial Officer 30 Jan 2026, 17:16
DAWN Day One Biopharmaceuticals, Inc. 15 Nov 2025 7 -$33,216 4 Chief Commercial Officer 18 Nov 2025, 19:00
DAWN Day One Biopharmaceuticals, Inc. 06 Nov 2025 6 $0 4 Chief Commercial Officer 07 Nov 2025, 17:58
DAWN Day One Biopharmaceuticals, Inc. 15 Aug 2025 7 -$25,485 4 Chief Commercial Officer 19 Aug 2025, 19:36
DAWN Day One Biopharmaceuticals, Inc. 15 May 2025 7 -$24,575 4 Chief Commercial Officer 19 May 2025, 17:54
DAWN Day One Biopharmaceuticals, Inc. 26 Feb 2025 0 $0 3 Chief Commercial Officer 28 Feb 2025, 19:50
EPIX ESSA Pharma Inc. 25 Mar 2024 1 $0 4 Director 28 Mar 2024, 12:36
EPIX ESSA Pharma Inc. 06 Jun 2023 0 $0 3 Director 06 Jun 2023, 16:30
/report/000120919123017722-merendino-lauren-2023-03-10 Myovant Sciences Ltd. 10 Mar 2023 4 $0 4 Chief Commercial Officer 10 Mar 2023, 08:31
/report/000120919123004283-merendino-lauren-2023-01-18 Myovant Sciences Ltd. 18 Jan 2023 1 -$53,995 4 Chief Commercial Officer 20 Jan 2023, 15:34
/report/000120919122054197-merendino-lauren-2022-10-18 Myovant Sciences Ltd. 18 Oct 2022 1 -$42,916 4 Chief Commercial Officer 20 Oct 2022, 16:54
/report/000120919122042690-merendino-lauren-2022-07-18 Myovant Sciences Ltd. 18 Jul 2022 1 -$21,930 4 Chief Commercial Officer 20 Jul 2022, 16:37
/report/000120919122025172-merendino-lauren-2022-04-19 Myovant Sciences Ltd. 19 Apr 2022 1 -$73,662 4 Chief Commercial Officer 21 Apr 2022, 16:25
/report/000120919122024785-merendino-lauren-2022-04-15 Myovant Sciences Ltd. 15 Apr 2022 1 $0 4 Chief Commercial Officer 19 Apr 2022, 16:48